Louis S. Matza
Louis gained experience in the development of patient-reported outcome (PRO) instruments for use in medical product evaluation and labeling through direct interaction with the U.S. Food and Drug Administration, and his research has focused largely on designing and directing PRO studies. Other primary areas of interest include utility assessment and psychiatric disorders.
Louis’ clinical experience in psychiatric and community mental health settings with child, adolescent and adult populations has given him insight into a broad range of psychiatric disorders. He has also focused on the interface between psychological and physiological functioning while working as a clinical psychologist in medical hospitals.
His publications have appeared in Archives of General Psychiatry, Medical Decision Making, Quality of Life Research, Value in Health, Journal of Clinical Psychiatry, Pharmacoeconomics, European Journal of Health Economics, Psychiatry Research, Supportive Care in Cancer, Journal of Affective Disorders, Journal of Attention Disorders, International Journal of Methods in Psychiatric Research, Annals of Pharmacotherapy, and many other peer-reviewed journals. He has made presentations at a wide range of scientific conferences including meetings of the International Society for Quality of Life Research, the American Psychological Association, the Society for Research in Child Development, the International Congress on Schizophrenia Research and the American Public Health Association. Louis is currently the chair of a PRO task force for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). This interdisciplinary task force is drafting a manuscript providing recommendations for developing and implementing PRO instruments for assessment of children and adolescents.
Louis earned a bachelor’s in psychology from the University of California at Berkeley, and master’s and doctoral degrees in clinical psychology at the University of North Carolina at Chapel Hill.